Mei Sheng Duh

Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.

Roberts MH, Duh MS, Rothnie KJ, Zhang S, Czira A, Slade D, Cheng WY, Thompson-Leduc P, Greatsinger A, Zhang A, Mapel D.

Respir Med. 2024 Apr 07. 226:107630. PMID: 38593886

HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States.

Yang X, Chang R, Dettling T, Desai R, Gao C, Banatwala A, Ng S, Ahsan S, Duh MS.

J Natl Compr Canc Netw. 2024 Apr 05. 22(2.5). PMID: 38579758

Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data.

Ailawadhi S, Cheng M, Cherepanov D, DerSarkissian M, Stull DM, Hilts A, Chun J, Duh MS, Sanchez L.

Curr Probl Cancer. 2024 Mar 27. 50:101078. PMID: 38547609

Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma.

Casale TB, Corbridge T, Germain G, Laliberté F, MacKnight SD, Boudreau J, Duh MS, Deb A.

Allergy Asthma Clin Immunol. 2024 Mar 26. 20(1):25. PMID: 38532489

Likelihood of Antimicrobial Resistance in Urinary E coli Isolates among US Female Patients with Recurrent vs Non-Recurrent Uncomplicated Urinary Tract Infection.

Fromer DL, Cheng WY, Gao C, Mahendran M, Hilts A, Duh MS, Joshi AV, Mulgirigama A, Mitrani-Gold FS.

Urology. 2024 Mar 11. PMID: 38467284

Dr Singer et al reply.

Singer D, Thompson-Leduc P, Poston S, Gupta D, Cheng WY, Ma S, Devine F, Duh MS, Curtis JR.

J Rheumatol. 2024 Mar 01. 51(3):324-326. PMID: 38428985

Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C).

Bell CF, Bobbili P, Desai R, Gibbons DC, Drysdale M, DerSarkissian M, Patel V, Birch HJ, Lloyd EJ, Zhang A, Duh MS.

Clin Drug Investig. 2024 Mar. 44(3):183-198. PMID: 38379107

Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis.

Creagh AP, Hamy V, Yuan H, Mertes G, Tomlinson R, Chen WH, Williams R, Llop C, Yee C, Duh MS, Doherty A, Garcia-Gancedo L, Clifton DA.

NPJ Digit Med. 2024 Feb 12. 7(1):33. PMID: 38347090

Real-world users of triple therapy for asthma in the US.

Hansel NN, Abbott CB, Averell CM, Germain G, Laliberté F, Mahendran M, Duh MS, Settipane RA.

Am J Manag Care. 2024 Feb. 30(2):74-81. PMID: 38381542

Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US.

Bogart M, Germain G, Laliberté F, Mahendran M, Duh MS, DiRocco K, Noorduyn SG, Paczkowski R, Balkissoon R.

J Asthma Allergy. 2023. 16:1309-1322. PMID: 38058516